$ICUI
ICU MEDICAL INC/DE Stock $icui

$icui Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000088398423000022 Filed on May 09, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$549.3M	$568.6M
YoY Change	-2.08%	4.7%
Cost Of Revenue	$357.0M	$376.6M
YoY Change	-9.26%	0.62%
Gross Profit	$192.3M	$192.0M
YoY Change	14.76%	13.75%
Gross Profit Margin	35.01%	33.77%
Selling, General & Admin	$150.9M	$152.6M
YoY Change	-4.95%	-0.42%
% of Gross Profit	78.46%	79.45%
Research & Development	$22.30M	$19.76M
YoY Change	-1.15%	-17.22%
% of Gross Profit	11.6%	10.29%
Depreciation & Amortization	$24.40M	$55.74M
YoY Change	-2.01%	4.9%
% of Gross Profit	12.69%	29.03%
Operating Expenses	$189.6M	$182.6M
YoY Change	13.08%	-13.43%
Operating Profit	$2.760M	$9.395M
YoY Change	-5850.0%	-122.28%
Interest Expense	$24.12M	$22.52M
YoY Change	48.23%	65.02%
% of Operating Profit	873.95%	239.65%
Other Income/Expense, Net	-$1.502M	-$269.0K
YoY Change	181.8%	-126.79%
Pretax Income	-$22.86M	-$13.39M
YoY Change	35.65%	-75.57%
Income Tax	-$12.93M	-$3.577M
% Of Pretax Income
Net Earnings	-$9.934M	-$9.812M
YoY Change	32.91%	-74.23%
Net Earnings / Revenue	-1.81%	-1.73%
Basic Earnings Per Share	-$0.41	-$0.41
Diluted Earnings Per Share	-$0.41	-$0.41
COMMON SHARES
Basic Shares Outstanding	24.06M shares	24.00M shares
Diluted Shares Outstanding	24.08M shares	24.01M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$197.7M	$224.2M
YoY Change	-26.48%	-34.89%
Cash & Equivalents	$195.9M	$220.9M
Short-Term Investments	$1.812M	$3.235M
Other Short-Term Assets	$3.022M	$3.539M
YoY Change	-20.87%	-9.7%
Inventory	$775.3M	$748.0M
Prepaid Expenses
Receivables	$162.2M	$139.5M
Other Receivables	$2.618M	$3.030M
Total Short-Term Assets	$1.245B	$1.213B
YoY Change	4.61%	3.32%
LONG-TERM ASSETS
Property, Plant & Equipment	$616.5M	$624.1M
YoY Change	-7.67%	-7.46%
Goodwill	$1.464B	$1.463B
YoY Change	3.04%	-4.2%
Intangibles	$929.8M	$957.7M
YoY Change	-13.93%	-12.52%
Long-Term Investments	$3.161M	$3.166M
YoY Change	-1.4%	-1.34%
Other Assets	$99.96M	$101.9M
YoY Change	-1.74%	-2.61%
Total Long-Term Assets	$3.218B	$3.258B
YoY Change	-5.35%	-8.82%
TOTAL ASSETS
Total Short-Term Assets	$1.245B	$1.213B
Total Long-Term Assets	$3.218B	$3.258B
Total Assets	$4.463B	$4.471B
YoY Change	-2.77%	-5.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$167.1M	$186.4M
YoY Change	-17.25%	-7.25%
Accrued Expenses	$254.5M	$235.2M
YoY Change	2.77%	-10.18%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$40.38M	$35.06M
YoY Change	111.8%	153.84%
Total Short-Term Liabilities	$483.9M	$462.2M
YoY Change	-0.43%	-6.46%
LONG-TERM LIABILITIES
Long-Term Debt	$1.601B	$1.612B
YoY Change	-2.16%	-1.83%
Other Long-Term Liabilities	$109.9M	$114.2M
YoY Change	-14.31%	-14.89%
Total Long-Term Liabilities	$1.711B	$1.726B
YoY Change	-3.04%	-2.81%
TOTAL LIABILITIES
Total Short-Term Liabilities	$483.9M	$462.2M
Total Long-Term Liabilities	$1.711B	$1.726B
Total Liabilities	$2.194B	$2.189B
YoY Change	-2.48%	-3.61%
SHAREHOLDERS EQUITY
Retained Earnings	$817.8M	$827.7M
YoY Change	-5.6%	-5.27%
Common Stock	$1.347B	$1.342B
YoY Change	2.7%	2.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.611M	$8.006M
YoY Change	1651.09%	181.6%
Treasury Stock Shares		50.37K shares
Shareholders Equity	$2.115B	$2.100B
YoY Change
Total Liabilities & Shareholders Equity	$4.463B	$4.471B
YoY Change	-2.77%	-5.82%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$9.934M	-$9.812M
YoY Change	32.91%	-74.23%
Depreciation, Depletion And Amortization	$24.40M	$55.74M
YoY Change	-2.01%	4.9%
Cash From Operating Activities	-$1.474M	$41.25M
YoY Change	-97.6%	-3173.4%
INVESTING ACTIVITIES
Capital Expenditures	$20.40M	$14.21M
YoY Change	-177.03%	-39.82%
Acquisitions		$0.00
YoY Change		-100.0%
Other Investing Activities	$2.797M	$1.554M
YoY Change	-86.86%	-100.08%
Cash From Investing Activities	-$17.61M	-$15.18M
YoY Change	239.1%	-99.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$7.375M
YoY Change		-53.91%
Cash From Financing Activities	-5.897M	-$15.84M
YoY Change	46.33%	-100.96%
NET CHANGE
Cash From Operating Activities	-1.474M	$41.25M
Cash From Investing Activities	-17.61M	-$15.18M
Cash From Financing Activities	-5.897M	-$15.84M
Net Change In Cash	-24.98M	$12.16M
YoY Change	-64.63%	-105.44%
FREE CASH FLOW
Cash From Operating Activities	-$1.474M	$41.25M
Capital Expenditures	$20.40M	$14.21M
Free Cash Flow	-$21.88M	$27.04M
YoY Change	-37.31%	-208.39%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000883984
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	ICU MEDICAL INC/DE
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	icui	Required Share Holding Of Stock Issued At Acquisition RequiredShareHoldingOfStockIssuedAtAcquisition	0.500
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	366-2183
CY2023Q1	icui	Minimum Stock Price Target For Earn Out Payment MinimumStockPriceTargetForEarnOutPayment	300.00	usd
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P9Y
CY2023Q1	us-gaap	Derivative Asset Current Statement Of Financial Position Extensible Enumeration DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssetsCurrent
CY2023Q1	us-gaap	Derivative Asset Noncurrent Statement Of Financial Position Extensible Enumeration DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2023Q1	us-gaap	Derivative Liability Current Statement Of Financial Position Extensible Enumeration DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
CY2023Q1	us-gaap	Derivative Liability Noncurrent Statement Of Financial Position Extensible Enumeration DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2022Q4	us-gaap	Derivative Asset Current Statement Of Financial Position Extensible Enumeration DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssetsCurrent
CY2022Q4	us-gaap	Derivative Asset Noncurrent Statement Of Financial Position Extensible Enumeration DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2022Q4	us-gaap	Derivative Liability Current Statement Of Financial Position Extensible Enumeration DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
CY2022Q4	us-gaap	Derivative Liability Noncurrent Statement Of Financial Position Extensible Enumeration DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2023Q1	us-gaap	Derivative Asset Current Statement Of Financial Position Extensible Enumeration DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssetsCurrent
CY2023Q1	us-gaap	Derivative Asset Noncurrent Statement Of Financial Position Extensible Enumeration DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2023Q1	us-gaap	Derivative Asset Current Statement Of Financial Position Extensible Enumeration DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssetsCurrent
CY2023Q1	us-gaap	Derivative Asset Noncurrent Statement Of Financial Position Extensible Enumeration DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2022Q4	us-gaap	Derivative Liability Current Statement Of Financial Position Extensible Enumeration DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
CY2023Q1	us-gaap	Derivative Liability Noncurrent Statement Of Financial Position Extensible Enumeration DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2022Q4	us-gaap	Derivative Asset Current Statement Of Financial Position Extensible Enumeration DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssetsCurrent
CY2022Q4	us-gaap	Derivative Liability Noncurrent Statement Of Financial Position Extensible Enumeration DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-34634
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	33-0022692
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	951 Calle Amanecer
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	San Clemente
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92673
CY2023Q1	dei	City Area Code CityAreaCode	949
CY2023Q1	dei	Security12b Title Security12bTitle	Common stock, par value $0.10 per share
CY2023Q1	dei	Trading Symbol TradingSymbol	ICUI
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	24064364	shares
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	220947000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	208784000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	3235000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	4224000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	224182000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	213008000	usd
CY2023Q1	icui	Minimum Stock Price Target For Earn Out Payment MinimumStockPriceTargetForEarnOutPayment	300.00	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	10337000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	8530000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	139459000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	221719000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	747965000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	696009000	usd
CY2023Q1	us-gaap	Prepaid Taxes PrepaidTaxes	14294000	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	15528000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	87125000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	88932000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	1213025000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1235196000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	624112000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	636113000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	79736000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	74864000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	0	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	516000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	1462726000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1449258000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	957682000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	982766000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	31466000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	31466000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	101885000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	105462000	usd
CY2023Q1	us-gaap	Assets Assets	4470632000	usd
CY2022Q4	us-gaap	Assets Assets	4515641000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	186420000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	215902000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	235167000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	242769000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	35063000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	29688000	usd
CY2023Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	5527000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	6200000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	462177000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	494559000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	24905000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	25572000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1612196000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1623675000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	114227000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	114104000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	114594000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	126007000	usd
CY2023Q1	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	42134000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	41796000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue	0	usd
CY2022Q4	us-gaap	Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue	0	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24114000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23995000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24064000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23993000	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	2411000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2399000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1339908000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1331249000	usd
CY2023Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	50374	shares
CY2022Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1633	shares
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	8006000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	243000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	827689000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	837501000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-61603000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-80978000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2100399000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2089928000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4470632000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4515641000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	568649000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	543122000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	376608000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	374295000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	192041000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	168827000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	152572000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	153212000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19761000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	23871000	usd
CY2023Q1	icui	Restructuringandstrategictransaction Restructuringandstrategictransaction	11013000	usd
CY2022Q1	icui	Restructuringandstrategictransaction Restructuringandstrategictransaction	33905000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-700000	usd
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	182646000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	210988000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	9395000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-42161000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	22515000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	13055000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-269000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	415000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13389000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-54801000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3577000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-16733000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-9812000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-38068000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.41
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.61
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.41
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.61
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24014000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23646000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24014000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23646000	shares
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-9812000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-38068000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	1744000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	-7312000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-5577000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	23572000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	24983000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-4946000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	0	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	0	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	31000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-15000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	19375000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	18641000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	9563000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19427000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2089928000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	171000	usd
CY2023Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	8425000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9158000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	19379000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-9812000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2100399000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1616031000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2974000	usd
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	8743000	usd
CY2022Q1	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	2500000	shares
CY2022Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	575975000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12092000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	18641000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-38068000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	2178902000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-9812000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-38068000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	55744000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	53138000	usd
CY2023Q1	icui	Amortization Of Inventory Step Up AmortizationOfInventoryStepUp	0	usd
CY2022Q1	icui	Amortization Of Inventory Step Up AmortizationOfInventoryStepUp	14370000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	5656000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	5286000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	666000	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-548000	usd
CY2023Q1	icui	Provision For Warranty And Returns ProvisionForWarrantyAndReturns	3951000	usd
CY2022Q1	icui	Provision For Warranty And Returns ProvisionForWarrantyAndReturns	726000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	9158000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	12092000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-367000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-596000	usd
CY2023Q1	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	5000	usd
CY2022Q1	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	130000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1701000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1643000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-700000	usd
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2023Q1	icui	Sparepartsusage Sparepartsusage	4384000	usd
CY2022Q1	icui	Sparepartsusage Sparepartsusage	2223000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	40000	usd
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1649000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-82028000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-22489000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	49370000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	36170000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1907000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2607000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	6448000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	14371000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-27525000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	19504000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-21099000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-19238000	usd
CY2023Q1	icui	Increase Decreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes	-9328000	usd
CY2022Q1	icui	Increase Decreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes	-26102000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	41245000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1342000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14205000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	23606000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	54000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	900000	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1844164000	usd
CY2023Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2532000	usd
CY2022Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2387000	usd
CY2023Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	usd
CY2022Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	1993000	usd
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	1500000	usd
CY2022Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	3500000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15183000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1867750000	usd
CY2023Q1	icui	Proceeds From Issuance Of Long Term Debt Net Of Lender Debt Issuance Costs ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts	0	usd
CY2022Q1	icui	Proceeds From Issuance Of Long Term Debt Net Of Lender Debt Issuance Costs ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts	1672698000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	7375000	usd
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	16000000	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1852000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	171000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2974000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	208000	usd
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	160000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	8425000	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	8743000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-15837000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1648917000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1938000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-3224000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	12163000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-223399000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	208784000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	552827000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	220947000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	329428000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2223000	usd
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	5178000	usd
CY2023Q1	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	4000000	usd
CY2023Q1	us-gaap	Related Party Transaction Due From To Related Party RelatedPartyTransactionDueFromToRelatedParty	1500000	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	1922955000	usd
CY2022Q1	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	563743000	usd
CY2023Q1	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-34994000	usd
CY2022Q1	icui	Pro Forma Adjustment Amortization ProFormaAdjustmentAmortization	3300000	usd
CY2022Q1	icui	Pro Forma Adjustment Finance Costs ProFormaAdjustmentFinanceCosts	800000	usd
CY2023Q1	icui	Restructuringstrategictransactionandintegration Restructuringstrategictransactionandintegration	11000000	usd
CY2022Q1	icui	Restructuringstrategictransactionandintegration Restructuringstrategictransactionandintegration	33900000	usd
CY2023Q1	us-gaap	Restructuring Costs RestructuringCosts	2700000	usd
CY2022Q1	us-gaap	Restructuring Costs RestructuringCosts	3200000	usd
CY2022Q4	us-gaap	Restructuring Reserve RestructuringReserve	5923000	usd
CY2023Q1	us-gaap	Restructuring Charges RestructuringCharges	2732000	usd
CY2023Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	1284000	usd
CY2023Q1	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	911000	usd
CY2023Q1	us-gaap	Restructuring Reserve Translation Adjustment RestructuringReserveTranslationAdjustment	-86000	usd
CY2023Q1	us-gaap	Restructuring Reserve RestructuringReserve	6546000	usd
CY2023Q1	icui	Strategic Transactionand Integration StrategicTransactionandIntegration	8300000	usd
CY2022Q1	icui	Strategic Transactionand Integration StrategicTransactionandIntegration	30700000	usd
CY2023Q1	us-gaap	Revenues Revenues	568649000	usd
CY2022Q1	us-gaap	Revenues Revenues	543122000	usd
CY2023Q1	us-gaap	Revenues Revenues	568649000	usd
CY2022Q1	us-gaap	Revenues Revenues	543122000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	225000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	45866000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	47511000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	7461000	usd
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	58236000	usd
CY2023Q1	icui	Optiontoextendinyears Optiontoextendinyears	P5Y
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	6150000	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	5178000	usd
CY2023Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	29000	usd
CY2022Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	29000	usd
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	170000	usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	13000	usd
CY2022Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	3000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	6417000	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	5380000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	6051000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	6548000	usd
CY2023Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	29000	usd
CY2022Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	29000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	8979000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1493000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	340000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	79736000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	74864000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	20150000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	18169000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	63062000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	60916000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	83212000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	79085000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y1M6D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0427
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0434
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2758000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2598000	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	903000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	816000	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1939000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1855000	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	2842000	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	2671000	usd
CY2023Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P4Y6M
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P4Y9M18D
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0447
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0423
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	17505000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	778000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	20211000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	766000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	14957000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	545000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	13244000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	423000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	9635000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	198000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	14315000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	189000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	3844000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	237000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	93711000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	3136000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	10499000	usd
CY2023Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	294000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	83212000	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	2842000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-9812000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-38068000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24014000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23646000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24014000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23646000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.41
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.61
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.41
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.61
CY2023Q1	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	101800000	usd
CY2023Q1	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	32993000	usd
CY2023Q1	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	19723000	usd
CY2023Q1	us-gaap	Derivative Assets DerivativeAssets	52716000	usd
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2132000	usd
CY2023Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	41000	usd
CY2023Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	2173000	usd
CY2022Q4	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	33291000	usd
CY2022Q4	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	26847000	usd
CY2022Q4	us-gaap	Derivative Assets DerivativeAssets	60138000	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1847000	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	167000	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	2014000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-133000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	33163000	usd
CY2023Q1	us-gaap	Derivative Net Hedge Ineffectiveness Gain Loss DerivativeNetHedgeIneffectivenessGainLoss	229000	usd
CY2022Q1	us-gaap	Derivative Net Hedge Ineffectiveness Gain Loss DerivativeNetHedgeIneffectivenessGainLoss	0	usd
CY2023Q1	us-gaap	Foreign Currency Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months	5300000	usd
CY2023Q1	us-gaap	Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet	26300000	usd
CY2023Q1	icui	Ownership Requirement For Earnout Payment OwnershipRequirementForEarnoutPayment	0.500
CY2023Q1	icui	Contingent Consideration Gross St ContingentConsiderationGrossST	1000000	usd
CY2023Q1	icui	Contingent Consideration Gross Lt ContingentConsiderationGrossLT	1500000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	25572000	usd
CY2023Q1	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	700000	usd
CY2023Q1	icui	Currency Translation On Earn Out CurrencyTranslationOnEarnOut	-33000	usd
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	24905000	usd
CY2022Q1	us-gaap	Business Combination Consideration Transferred Liabilities Incurred BusinessCombinationConsiderationTransferredLiabilitiesIncurred	55158000	usd
CY2022Q1	icui	Currency Translation On Earn Out CurrencyTranslationOnEarnOut	46000	usd
CY2023Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	55951000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	516000	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	64878000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	3235000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesGrossUnrealizedLoss	0	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	3235000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	4740000	usd
CY2022	us-gaap	Available For Sale Debt Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesGrossUnrealizedLoss	0	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	4740000	usd
CY2023Q1	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	3300000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	3166000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	3178000	usd
CY2023Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	26332000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	21635000	usd
CY2023Q1	icui	Prepaid Vendor Expenses PrepaidVendorExpenses	1862000	usd
CY2022Q4	icui	Prepaid Vendor Expenses PrepaidVendorExpenses	3052000	usd
CY2023Q1	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	3638000	usd
CY2022Q4	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	2395000	usd
CY2023Q1	icui	Prepaidinsuranceandpropertytaxes Prepaidinsuranceandpropertytaxes	10638000	usd
CY2022Q4	icui	Prepaidinsuranceandpropertytaxes Prepaidinsuranceandpropertytaxes	16322000	usd
CY2023Q1	icui	Prepaidothertaxes Prepaidothertaxes	3030000	usd
CY2022Q4	icui	Prepaidothertaxes Prepaidothertaxes	3546000	usd
CY2023Q1	icui	Deferredtaxcharge Deferredtaxcharge	3830000	usd
CY2022Q4	icui	Deferredtaxcharge Deferredtaxcharge	3830000	usd
CY2023Q1	us-gaap	Deposit Assets DepositAssets	1263000	usd
CY2022Q4	us-gaap	Deposit Assets DepositAssets	1329000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	3539000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3532000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	87125000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	88932000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	28821000	usd
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	27086000	usd
CY2023Q1	icui	Spare Parts SpareParts	40598000	usd
CY2022Q4	icui	Spare Parts SpareParts	38498000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	3166000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	3178000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	4727000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	5156000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2758000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2598000	usd
CY2023Q1	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	2143000	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	2193000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	101885000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	105462000	usd
CY2023Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	317340000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	286964000	usd
CY2023Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	73708000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	73795000	usd
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	356917000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	335250000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	747965000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	696009000	usd
CY2023Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	430258000	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	414811000	usd
CY2023Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	30166000	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	29876000	usd
CY2023Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	138996000	usd
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	152909000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1174544000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1162557000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	550432000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	526444000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	624112000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	636113000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	23400000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	21400000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1449258000	usd
CY2023Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	13468000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	1462726000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1209215000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	285135000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	924080000	usd
CY2023Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	33602000	usd
CY2023Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	33602000	usd
CY2023Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	1242817000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	285135000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	957682000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1202911000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	251951000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	950960000	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	31806000	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	31806000	usd
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	1234717000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	251951000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	982766000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	32300000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	31700000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	98853000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	131665000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	124073000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	123438000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	117400000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	110442000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	218209000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	924080000	usd
CY2023Q1	icui	Accrued Salaries And Benefits AccruedSalariesAndBenefits	47808000	usd
CY2022Q4	icui	Accrued Salaries And Benefits AccruedSalariesAndBenefits	44304000	usd
CY2023Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	22579000	usd
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	30254000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	20150000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	18169000	usd
CY2023Q1	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	6158000	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	5844000	usd
CY2023Q1	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	6546000	usd
CY2022Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	5923000	usd
CY2023Q1	icui	Unfavorablecontractliability St UnfavorablecontractliabilityST	30991000	usd
CY2022Q4	icui	Unfavorablecontractliability St UnfavorablecontractliabilityST	30838000	usd
CY2023Q1	icui	Accruedothertaxes Accruedothertaxes	2524000	usd
CY2022Q4	icui	Accruedothertaxes Accruedothertaxes	5794000	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	6823000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	5317000	usd
CY2023Q1	icui	Accruedlegalfees Accruedlegalfees	3137000	usd
CY2022Q4	icui	Accruedlegalfees Accruedlegalfees	3137000	usd
CY2023Q1	icui	Outsidesalescommissions Outsidesalescommissions	11502000	usd
CY2022Q4	icui	Outsidesalescommissions Outsidesalescommissions	17063000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	3201000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	3097000	usd
CY2023Q1	icui	Field Service Corrective Action FieldServiceCorrectiveAction	27898000	usd
CY2022Q4	icui	Field Service Corrective Action FieldServiceCorrectiveAction	24517000	usd
CY2023Q1	icui	Accruedfreight Accruedfreight	11116000	usd
CY2022Q4	icui	Accruedfreight Accruedfreight	17988000	usd
CY2023Q1	icui	Accrued Research And Development AccruedResearchAndDevelopment	6562000	usd
CY2022Q4	icui	Accrued Research And Development AccruedResearchAndDevelopment	3538000	usd
CY2023Q1	icui	Accrued Audit Fees AccruedAuditFees	6355000	usd
CY2022Q4	icui	Accrued Audit Fees AccruedAuditFees	6279000	usd
CY2023Q1	us-gaap	Pension And Other Postretirement Defined Benefit Plans Current Liabilities PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities	2974000	usd
CY2022Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Current Liabilities PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities	2928000	usd
CY2023Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	693000	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1033000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	16018000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	14899000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	235167000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	242769000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	63062000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	60916000	usd
CY2023Q1	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	5252000	usd
CY2022Q4	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	5314000	usd
CY2023Q1	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	955000	usd
CY2022Q4	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	997000	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1939000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1855000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	16591000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	16239000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	1134000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	3489000	usd
CY2023Q1	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	114227000	usd
CY2022Q4	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	114104000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.27
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.31
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	700000	usd
CY2023Q1	icui	Contingent Consideration Tax Expense ContingentConsiderationTaxExpense	0	usd
CY2022Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	2600000	usd
CY2023Q1	icui	Total Senior Secured Credit Facility TotalSeniorSecuredCreditFacility	2200000000	usd
CY2023Q1	icui	Revolver Sub Limits RevolverSubLimits	50000000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	37800000	usd
CY2023Q1	icui	Interest Percentage Added To Federal Funds Rate InterestPercentageAddedToFederalFundsRate	0.0050
CY2023Q1	icui	Interest Percentage Added To Base Rate InterestPercentageAddedToBaseRate	0.0100
CY2023Q1	icui	Ter Sofr Interest Rate Adjustment For Base Rate Loans TerSOFRInterestRateAdjustmentForBaseRateLoans	0.0010
CY2023Q1	us-gaap	Line Of Credit Facility Commitment Fee Percentage LineOfCreditFacilityCommitmentFeePercentage	0.0025
CY2023Q1	icui	Term A Principal Payment First2 Years TermAPrincipalPaymentFirst2Years	0.0250
CY2023Q1	icui	Term A Principal Payment Year3 And4 TermAPrincipalPaymentYear3And4	0.0500
CY2023Q1	icui	Term A Principal Payment In Year5 TermAPrincipalPaymentInYear5	0.0750
CY2023Q1	icui	Term Loan B Principal Payment TermLoanBPrincipalPayment	0.0025
CY2022Q1	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	16000000	usd
CY2023Q1	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	7400000	usd
CY2023Q1	icui	Leverage Ratio Calculation Ceiling Subtracted Amount LeverageRatioCalculationCeilingSubtractedAmount	500000000	usd
CY2023Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	150000000	usd
CY2023Q1	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2022-11-08
CY2023Q1	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	0	usd
CY2022Q4	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	0	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	-22991000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	-24262000	usd
CY2023Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1647259000	usd
CY2022Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1653363000	usd
CY2023Q1	us-gaap	Debt Current DebtCurrent	35063000	usd
CY2022Q4	us-gaap	Debt Current DebtCurrent	29688000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1612196000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1623675000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	22312000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	51000000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	51000000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	72250000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	672563000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	8500000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	792625000	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1670250000	usd
CY2023Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	29263000	usd
CY2022Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	10017000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1701000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1643000	usd
CY2023Q1	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	368000	usd
CY2022Q1	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	351000	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	31332000	usd
CY2022Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	12011000	usd
CY2023Q1	icui	Smiths Group Ownership Acquisition Shares Issued SmithsGroupOwnershipAcquisitionSharesIssued	0.105
CY2023Q1	icui	Smiths Group Ownership Required For Board Representation SmithsGroupOwnershipRequiredForBoardRepresentation	0.050
CY2023Q1	icui	Treasury Stock Purchase Plan TreasuryStockPurchasePlan	100000000	usd
CY2023Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	100000000	usd
CY2023Q1	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	52764	shares
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	8400000	usd
CY2022Q1	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	37279	shares
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	8700000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-80978000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	24839000	usd
CY2023Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-5464000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	19375000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-61603000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-19269000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	20851000	usd
CY2022Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-2210000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	18641000	usd
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-628000	usd
CY2022Q1	us-gaap	Product Liability Accrual Component Amount ProductLiabilityAccrualComponentAmount	55100000	usd
CY2023Q1	us-gaap	Product Liability Accrual Component Amount ProductLiabilityAccrualComponentAmount	48600000	usd
CY2023Q1	icui	Contingent Consideration Gross St ContingentConsiderationGrossST	1000000	usd
CY2023Q1	icui	Contingent Consideration Gross Lt ContingentConsiderationGrossLT	1500000	usd
CY2023Q1	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	29600000	usd
CY2023Q1	us-gaap	Financing Receivable Revolving FinancingReceivableRevolving	150000000	usd
CY2023Q1	us-gaap	Accounts Receivable Sale AccountsReceivableSale	139600000	usd
CY2023Q1	us-gaap	Proceeds From Sale And Collection Of Receivables ProceedsFromSaleAndCollectionOfReceivables	138800000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Accounts Receivable GainLossOnSaleOfAccountsReceivable	800000	usd
CY2023Q1	icui	Cash Remitted To Purchaser CashRemittedToPurchaser	81600000	usd
CY2023Q1	us-gaap	Transfer Of Financial Assets Accounted For As Sales Cash Proceeds Received For Assets Derecognized Amount TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount	58000000	usd

Files In Submission

Name	View Source	Status
icui-20230331_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
icui-20230331_lab.xml	Edgar Link	unprocessable
0000883984-23-000022-index-headers.html	Edgar Link	pending
0000883984-23-000022-index.html	Edgar Link	pending
0000883984-23-000022.txt	Edgar Link	pending
0000883984-23-000022-xbrl.zip	Edgar Link	pending
exhibit10133123.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
icui-20230331.htm	Edgar Link	pending
icui-20230331.xsd	Edgar Link	pending
icui-ex31133123.htm	Edgar Link	pending
icui-ex31233123.htm	Edgar Link	pending
icui-ex32133123.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
icui-20230331_def.xml	Edgar Link	unprocessable
icui-20230331_pre.xml	Edgar Link	unprocessable
icui-20230331_htm.xml	Edgar Link	completed
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ICUI
ICU MEDICAL INC/DE Stock $icui

2023 Q2 Form 10-Q Financial Statement

#000088398423000022 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICUI ICU MEDICAL INC/DE Stock $icui

2023 Q2 Form 10-Q Financial Statement

#000088398423000022 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICUI
ICU MEDICAL INC/DE Stock $icui